Tenet Healthcare (NYSE:THC) Reaches New 52-Week High Following Earnings Beat

Tenet Healthcare Corporation (NYSE:THC)’s stock price reached a new 52-week high during mid-day trading on Thursday following a stronger than expected earnings report. The stock traded as high as $229.00 and last traded at $225.86, with a volume of 3392868 shares changing hands. The stock had previously closed at $193.04.

The company reported $4.70 EPS for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The business had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. During the same period in the prior year, the firm earned $3.44 EPS. The company’s revenue for the quarter was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS.

Analyst Upgrades and Downgrades

THC has been the subject of several research reports. TD Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a report on Thursday. Barclays upped their price objective on shares of Tenet Healthcare from $240.00 to $257.00 and gave the stock an “overweight” rating in a research note on Friday. Cantor Fitzgerald raised their target price on shares of Tenet Healthcare from $190.00 to $245.00 and gave the company an “overweight” rating in a research report on Wednesday, October 29th. Raymond James Financial set a $245.00 price target on shares of Tenet Healthcare in a research report on Wednesday, October 29th. Finally, Morgan Stanley reissued an “overweight” rating and set a $260.00 price objective on shares of Tenet Healthcare in a report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $242.82.

Insider Activity

In other news, Director Nadja West sold 2,178 shares of the stock in a transaction on Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the sale, the director owned 28,480 shares in the company, valued at approximately $5,623,945.60. This represents a 7.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.81% of the company’s stock.

Institutional Investors Weigh In On Tenet Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in THC. NewEdge Advisors LLC increased its holdings in shares of Tenet Healthcare by 6.1% during the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock valued at $389,000 after acquiring an additional 166 shares in the last quarter. Jones Financial Companies Lllp grew its position in Tenet Healthcare by 299.1% during the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock worth $229,000 after purchasing an additional 1,274 shares during the last quarter. Sivia Capital Partners LLC acquired a new position in Tenet Healthcare during the 2nd quarter valued at approximately $290,000. Blue Trust Inc. raised its holdings in shares of Tenet Healthcare by 58.5% in the second quarter. Blue Trust Inc. now owns 271 shares of the company’s stock worth $48,000 after buying an additional 100 shares during the last quarter. Finally, Concurrent Investment Advisors LLC grew its holdings in shares of Tenet Healthcare by 4.6% during the second quarter. Concurrent Investment Advisors LLC now owns 5,048 shares of the company’s stock valued at $888,000 after buying an additional 224 shares during the last quarter. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Tenet Healthcare Stock Performance

The stock has a market capitalization of $20.29 billion, a price-to-earnings ratio of 14.91, a P/E/G ratio of 0.97 and a beta of 1.44. The company has a current ratio of 1.76, a quick ratio of 1.64 and a debt-to-equity ratio of 2.18. The firm has a 50-day moving average of $198.82 and a 200-day moving average of $194.69.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.